Merck & Co buys VelosBio for $2.75 billion

5 November 2020
merck_large

Some six months on from its last acquisition, US pharma giant Merck & Co (NYSE: MRK) has announced that it is to acquire VelosBio for $2.75 billion.

San Diego-based VelosBio is a privately held clinical-stage biopharmaceutical company committed to developing cancer therapies targeting receptor tyrosine kinase-like orphan receptor 1 (ROR1).

"At Merck, we continue to bolster our growing oncology pipeline with strategic acquisitions"VelosBio’s lead candidate is VLS-101, an antibody-drug conjugate targeting ROR1 that is currently being evaluated in a Phase I and a Phase II trial for the treatment of patients with hematologic malignancies and solid tumors, respectively.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Biotechnology